Of the myriad hepatic proteins that IL-6 induces with cardiovascular activities, it is increasingly clear that IL-6 is a major modulator of the coagulation pathway [125-127], where its actions shift hemostatic balance to prothrombosis, thereby increasing the risk of cardiovascular diseases. The gene discussed is IL6; the disease is cardiovascular disorder.